BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1156040)

  • 21. Sympathomimetic drugs: evaluation for acute central hypotensive activity in alpha-chloralose-anesthetized dogs and cats intravertebral artery administration,
    Kaplan HR; Fox JH; Kopia GA; Commarato MA
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):216-32. PubMed ID: 984975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats.
    Tibirica E; Feldman J; Bousquet P
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1062-6. PubMed ID: 2855238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits.
    Kim YI; Paik YH; Kang SS; Kim JH
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):66-76. PubMed ID: 6126161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of clonidine at steady state on blood pressure in spontaneously hypertensive rats. Interaction of various alpha-adrenoceptor antagonists.
    Frisk-Holmberg M
    Acta Physiol Scand; 1984 Jan; 120(1):37-42. PubMed ID: 6144238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypotensive action of a new benzimidazolinone derivative, threo-1-(2-hydroxy-2-(3,4,5-trimethoxyphenyl)-1-methylethyl)-4-(1,3-dihydro-2H-benzimidazol-2-one-1-yl)piperidine (KF-4942): prazosin-like mode of action.
    Karasawa A; Shuto K; Kubo K; Kasuya Y; Hashikami M; Shigenobu K
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):278-90. PubMed ID: 6132590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: A centrally-acting antihypertensive agent R28935, a pimozide analogue, not acting via alpha-adrenergic neurones.
    Finch L
    Br J Pharmacol; 1975 Oct; 55(2):313P-314P. PubMed ID: 1201440
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship between activity and structure in derivatives of clonidine.
    Hoefke W; Kobinger W; Walland A
    Arzneimittelforschung; 1975 May; 25(5):786-93. PubMed ID: 1242325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nifedipine and verapamil on hypotensive action of clonidine in rabbits.
    Czarnecka E; Tymczyszyn W; Pietrzak B
    Pol J Pharmacol; 1998; 50(3):193-201. PubMed ID: 9861627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular effects and interaction with adrenoceptors of urapidil.
    van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central hypotensive action of bridge analogues of clonidine.
    Timmermans PB; Mackay JC; Fluitman PH; van Zwieten PA
    Pharmacology; 1979; 19(6):294-300. PubMed ID: 549031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal experiments on the cardiovascular effects of lofexidine.
    Graf E; Doppelfeld IS; Prop G
    Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cardiovascular effects of intraventricular clonidine and Bay 1470 in conscious hypertensive cats.
    Finch L
    Br J Pharmacol; 1974 Nov; 52(3):333-8. PubMed ID: 4156484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
    Kawasaki H; Takasaki K
    J Pharmacol Exp Ther; 1986 Mar; 236(3):810-8. PubMed ID: 3005557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
    Sanders KH; Beller KD; Bischler P; Kolassa N
    J Hypertens Suppl; 1988 Dec; 6(2):S65-8. PubMed ID: 2906703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines.
    Bousquet P; Feldman J; Schwartz J
    J Pharmacol Exp Ther; 1984 Jul; 230(1):232-6. PubMed ID: 6146707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Morales-Olivas FJ; Palop V; Rubio E; Esplugues J
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):71-8. PubMed ID: 6151381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
    Salvati P; Bianchi G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypotensive and bradycardic activities of clonidine and related imidazolidines; structure-activity relationship.
    Timmermans PB; Van Zwieten PA
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):237-50. PubMed ID: 921414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.